secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2023-05-26T23:59:59+00:00
Accession:  0001104659-23-065107
Event type: debt
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Acura receives $150K loan from 66% owner AD Pharma; warns of possible shutdown if no more funding
--------------------------------------------------------------------------------

- Loan from Abuse Deterrent Pharma adds to $2.32M note, total debt $3.47M at 5.25%, due Dec 31, 2023.
- Also received $235K from CARES Act employee retention credit; funds expected to last through June 2023.
- If additional financing not secured by end of June 2023, may scale back operations or seek bankruptcy.
- AD Pharma owns ~66% of common stock; entity controlled by Mr. Schutte who holds ~14% directly.
- Overdue amounts bear interest at 7.5% per annum after 5-day grace period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465923065107/0001104659-23-065107-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465923065107/tm2317061d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-065107

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer